These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7197542)

  • 1. [Penetration and antifungal activity of ciclopiroxolamine in hornified tissue (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1353-9. PubMed ID: 7197542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological laboratory studies with ciclopiroxolamine (author's transl)].
    Dittmar W; Grau W; Raether W; Schrinner E; Wagner WH
    Arzneimittelforschung; 1981; 31(8A):1317-22. PubMed ID: 7197538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].
    Kellner HM; Arnold C; Christ OE; Eckert HG; Herok J; Hornke I; Rupp W
    Arzneimittelforschung; 1981; 31(8A):1337-53. PubMed ID: 7197541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].
    Petri W
    Arzneimittelforschung; 1981; 31(8A):1332-7. PubMed ID: 7197540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
    Adam W; Peil HG; Savopoulos C; Vanderbeke O
    Arzneimittelforschung; 1981; 31(8A):1360-5. PubMed ID: 7028047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)].
    Qadripur SA; Horn G; Höhler T
    Arzneimittelforschung; 1981; 31(8A):1369-72. PubMed ID: 6457608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-European open clinical studies on the efficacy and tolerance of ciclopiroxolamine in dermatomycoses (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1381-5. PubMed ID: 7028052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)].
    Iwata K; Yamaguchi H
    Arzneimittelforschung; 1981; 31(8A):1323-7. PubMed ID: 7028046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the pharmacology and toxicology of ciclopiroxolamine (author's transl)].
    Alpermann HG; Schütz E
    Arzneimittelforschung; 1981; 31(8A):1328-32. PubMed ID: 7197539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
    Fredriksson T; Savopoulos C
    Arzneimittelforschung; 1981; 31(8A):1376-8. PubMed ID: 7028050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
    Peil HG
    Arzneimittelforschung; 1981; 31(8A):1366-8. PubMed ID: 7028048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)].
    Torres J; Savopoulos C; Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1373-6. PubMed ID: 7028049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antifungal spectrum of ciclopiroxolamine].
    Goudard M; Regli P; Lubrano N
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):621-3. PubMed ID: 2797886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous absorption of isoconazole in humans (author's transl)].
    Täuber U
    Mykosen; 1979 Jul; 22(7):223-32. PubMed ID: 470977
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on uptake of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) by Candida albicans.
    Sakurai K; Sakaguchi T; Yamaguchi H; Iwata K
    Chemotherapy; 1978; 24(3):146-53. PubMed ID: 350513
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase of the transdermal penetration of testosterone by miconazole nitrate.
    Baert B; Roche N; Burvenich C; De Spiegeleer B
    Arch Pharm Res; 2012 Dec; 35(12):2163-70. PubMed ID: 23263811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream].
    Beyer M
    Arzneimittelforschung; 1981; 31(8A):1378-81. PubMed ID: 7028051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum.
    Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Lagarde I; Vandermander J; Michel G
    Skin Pharmacol; 1991; 4(2):95-9. PubMed ID: 1878248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics.
    Hänel H; Raether W; Dittmar W
    Ann N Y Acad Sci; 1988; 544():329-37. PubMed ID: 3214073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The chemistry of antimicrobially active 1-hydroxy-2-pyridones (author's transl)].
    Lohaus G; Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1311-6. PubMed ID: 7197537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.